Dermata Therapeutics, Inc. (DRMA)
1.30
-0.05
(-3.70%)
USD |
NASDAQ |
May 29, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Dermata Therapeutics EPS Diluted (Quarterly) : -0.4788 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| Perspective Therapeutics, Inc. | -0.2528 |
| MiMedx Group, Inc. | -0.0732 |
| ABVC BioPharma, Inc. | -0.0613 |
| Endonovo Therapeutics, Inc. | -0.0005 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.848M |
| Total Expenses (Quarterly) | 1.848M |
| Enterprise Value | -1.717M |
| Earnings Yield | -408.1% |
| Normalized Earnings Yield | -408.15 |